Index by author

March 01, 2005; Volume 16,Issue 3 suppl 1

Looking for COVID information? All ASN Journal COVID articles are in the COVID-19 Research Collection or the COVID-19 In Context Collection. All articles are free.​

A

  1. Amann, Kerstin

    1. Nephron Number and Renal Risk in Hypertension and Diabetes
      Marie-Luise Groβ, Kerstin Amann and Eberhard Ritz
      JASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967

B

  1. Berla, Maya

    1. Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
      Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai Ravid
      JASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965

  2. Bilous, Rudy

    1. Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
      Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo Viberti
      JASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973

  3. Bruseghin, Marino

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

C

  1. Campese, Vito M.

    1. Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?
      Vito M. Campese, Mitra K. Nadim and Murray Epstein
      JASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958

  2. Casadevall, Nicole

    1. Epoetin-Induced Autoimmune Pure Red Cell Aplasia
      Nicole Casadevall, Kai-Uwe Eckardt and Jérôme Rossert
      JASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959

  3. Cernigoi, Anna Maria

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  4. Chiurchiu, Carlos

    1. Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
      Carlos Chiurchiu, Giuseppe Remuzzi and Piero Ruggenenti
      JASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968

  5. Codreanu, Igor

    1. Dual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?
      Igor Codreanu, Norberto Perico and Giuseppe Remuzzi
      JASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966

D

  1. Dalla Vestra, Michele

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  2. Deferrari, Giacomo

    1. Introduction
      Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S1; DOI: https://doi.org/10.1681/ASN.2004110975
    2. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    3. Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
      Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
    4. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  3. de Zeeuw, Dick

    1. Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
      Liffert Vogt, Gerjan Navis and Dick de Zeeuw
      JASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074

E

  1. Eckardt, Kai-Uwe

    1. Epoetin-Induced Autoimmune Pure Red Cell Aplasia
      Nicole Casadevall, Kai-Uwe Eckardt and Jérôme Rossert
      JASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959

  2. Epstein, Murray

    1. Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?
      Vito M. Campese, Mitra K. Nadim and Murray Epstein
      JASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958

F

  1. Falqui, Valeria

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  2. Fioretto, Paola

    1. Antihypertensive Treatment and Multifactorial Approach for Renal Protection in Diabetes
      Paola Fioretto and Anna Solini
      JASN March 2005, 16 (3 suppl 1) S18-S21; DOI: https://doi.org/10.1681/ASN.2004110962
    2. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  3. Frommer-Shapira, Ronni

    1. Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
      Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai Ravid
      JASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965

G

  1. Gallina, Pietro

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  2. García-Donaire, José A.

    1. Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
      Julián Segura, José A. García-Donaire and Luis M. Ruilope
      JASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969

  3. Gesualdo, Loreto

    1. Pathogenetic Mechanisms of Diabetic Nephropathy
      Francesco P. Schena and Loreto Gesualdo
      JASN March 2005, 16 (3 suppl 1) S30-S33; DOI: https://doi.org/10.1681/ASN.2004110970

  4. Grassi, Guido

    1. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?
      Giuseppe Mancia and Guido Grassi
      JASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963

  5. Groβ, Marie-Luise

    1. Nephron Number and Renal Risk in Hypertension and Diabetes
      Marie-Luise Groβ, Kerstin Amann and Eberhard Ritz
      JASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967

K

  1. Karalliedde, Janaka

    1. Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
      Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo Viberti
      JASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973

  2. Krimholtz, Michael J.

    1. Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
      Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo Viberti
      JASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973

L

  1. Leoncini, Giovanna

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

M

  1. Mallamaci, Francesca

    1. Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
      Giovanni Tripepi, Francesca Mallamaci and Carmine Zoccali
      JASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972

  2. Mancia, Giuseppe

    1. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?
      Giuseppe Mancia and Guido Grassi
      JASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963

  3. Morganti, Alberto

    1. Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No
      Alberto Morganti
      JASN March 2005, 16 (3 suppl 1) S70-S73; DOI: https://doi.org/10.1681/ASN.2004110964

  4. Mussap, Michele

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

N

  1. Nadim, Mitra K.

    1. Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?
      Vito M. Campese, Mitra K. Nadim and Murray Epstein
      JASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958

  2. Navis, Gerjan

    1. Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
      Liffert Vogt, Gerjan Navis and Dick de Zeeuw
      JASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074

P

  1. Parodi, Angelica

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  2. Parodi, Denise

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
      Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
    3. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  3. Perico, Norberto

    1. Dual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?
      Igor Codreanu, Norberto Perico and Giuseppe Remuzzi
      JASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966

  4. Plebani, Mario

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  5. Pontremoli, Roberto

    1. Introduction
      Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S1; DOI: https://doi.org/10.1681/ASN.2004110975
    2. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    3. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

R

  1. Rachmani, Rita

    1. Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
      Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai Ravid
      JASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965

  2. Ratto, Elena

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
      Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
    3. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  3. Ravera, Maura

    1. Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
      Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957

  4. Ravid, Mordchai

    1. Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
      Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai Ravid
      JASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965

  5. Remuzzi, Giuseppe

    1. Dual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?
      Igor Codreanu, Norberto Perico and Giuseppe Remuzzi
      JASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966
    2. Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
      Carlos Chiurchiu, Giuseppe Remuzzi and Piero Ruggenenti
      JASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968

  6. Ritz, Eberhard

    1. Nephron Number and Renal Risk in Hypertension and Diabetes
      Marie-Luise Groβ, Kerstin Amann and Eberhard Ritz
      JASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967

  7. Rossert, Jérôme

    1. Epoetin-Induced Autoimmune Pure Red Cell Aplasia
      Nicole Casadevall, Kai-Uwe Eckardt and Jérôme Rossert
      JASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959

  8. Ruggenenti, Piero

    1. Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
      Carlos Chiurchiu, Giuseppe Remuzzi and Piero Ruggenenti
      JASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968

  9. Ruilope, Luis M.

    1. Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
      Julián Segura, José A. García-Donaire and Luis M. Ruilope
      JASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969

S

  1. Saller, Alois

    1. Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
      Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
      JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

  2. Schächinger, Volker

    1. Stem Cells and Cardiovascular and Renal Disease: Today and Tomorrow
      Volker Schächinger and Andreas M. Zeiher
      JASN March 2005, 16 (3 suppl 1) S2-S6; DOI: https://doi.org/10.1681/ASN.2004110971

  3. Schena, Francesco P.

    1. Pathogenetic Mechanisms of Diabetic Nephropathy
      Francesco P. Schena and Loreto Gesualdo
      JASN March 2005, 16 (3 suppl 1) S30-S33; DOI: https://doi.org/10.1681/ASN.2004110970

  4. Segura, Julián

    1. Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
      Julián Segura, José A. García-Donaire and Luis M. Ruilope
      JASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969

  5. Slavacheski, Inna

    1. Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
      Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai Ravid
      JASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965

  6. Solini, Anna

    1. Antihypertensive Treatment and Multifactorial Approach for Renal Protection in Diabetes
      Paola Fioretto and Anna Solini
      JASN March 2005, 16 (3 suppl 1) S18-S21; DOI: https://doi.org/10.1681/ASN.2004110962

T

  1. Thomas, Stephen

    1. Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
      Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo Viberti
      JASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973

  2. Tomolillo, Cinzia

    1. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  3. Tripepi, Giovanni

    1. Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
      Giovanni Tripepi, Francesca Mallamaci and Carmine Zoccali
      JASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972

V

  1. Vaccaro, Valentina

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  2. Vettoretti, Simone

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
      Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
    3. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  3. Viazzi, Francesca

    1. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
      Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari
      JASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
    2. Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
      Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
      JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

  4. Viberti, Giancarlo

    1. Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
      Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo Viberti
      JASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973

  5. Vogt, Liffert

    1. Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
      Liffert Vogt, Gerjan Navis and Dick de Zeeuw
      JASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074

Y

  1. Yale, Jean-François

    1. Oral Antihyperglycemic Agents and Renal Disease: New Agents, New Concepts
      Jean-François Yale
      JASN March 2005, 16 (3 suppl 1) S7-S10; DOI: https://doi.org/10.1681/ASN.2004110974

Z

  1. Zeiher, Andreas M.

    1. Stem Cells and Cardiovascular and Renal Disease: Today and Tomorrow
      Volker Schächinger and Andreas M. Zeiher
      JASN March 2005, 16 (3 suppl 1) S2-S6; DOI: https://doi.org/10.1681/ASN.2004110971

  2. Zoccali, Carmine

    1. Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
      Giovanni Tripepi, Francesca Mallamaci and Carmine Zoccali
      JASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972
Back to top

In this issue

View Selected Citations (0)